Altamira Therapeutics Ltd. Profit Loss Before Tax
Altamira Therapeutics Ltd. (CYTOF) reported Profit Loss Before Tax of -$8.46 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:ProfitLossBeforeTax · last filed 2025-04-30
CHF
| Period end | Profit Loss Before Tax 6 month | Profit Loss Before Tax 6 month as first filed | Profit Loss Before Tax 12 month | Profit Loss Before Tax 12 month as first filed |
|---|---|---|---|---|
| 2023-12-31 | -7.27M CHF 20-F/A · filed 2024-04-22 | |||
| 2023-06-30 | -5.41M CHF 6-K · filed 2023-09-12 | |||
| 2022-12-31 | -18.66M CHF 20-F/A · filed 2024-04-22 | -26.54M CHF 20-F · filed 2023-05-16 | ||
| 2022-06-30 | -8.28M CHF 6-K · filed 2023-09-12 | -7.35M CHF 6-K · filed 2022-11-30 | ||
| 2021-12-31 | -6.81M CHF 20-F/A · filed 2024-04-22 | -17.37M CHF 20-F · filed 2022-04-12 | ||
| 2021-06-30 | -6.77M CHF 6-K/A · filed 2023-08-21 | |||
| 2020-12-31 | -8.22M CHF 20-F · filed 2023-05-16 | |||
| 2020-06-30 | -2.67M CHF 6-K · filed 2021-09-08 | |||
| 2019-12-31 | -6.83M CHF 20-F · filed 2022-04-12 | |||
| 2019-06-30 | -3.87M CHF 6-K/A · filed 2020-09-17 | |||
| 2018-12-31 | -11.33M CHF 20-F · filed 2021-03-31 | |||
| 2018-06-30 | -4.84M CHF 6-K · filed 2019-08-15 | |||
| 2017-12-31 | -24.43M CHF 20-F · filed 2020-04-16 | |||
| 2016-12-31 | -30.79M CHF 20-F · filed 2019-03-14 | |||
| 2015-12-31 | -29.71M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Profit Loss Before Tax 12 month | Profit Loss Before Tax 12 month as first filed |
|---|---|---|
| 2024-12-31 | -$8.46M 20-F · filed 2025-04-30 | |
| 2023-12-31 | -$8.09M 20-F · filed 2025-04-30 | -$7.27M 20-F/A · filed 2024-04-22 |
| 2022-12-31 | -$19.54M 20-F · filed 2025-04-30 | -$18.66M 20-F/A · filed 2024-04-22 |
| 2021-12-31 | -$6.81M 20-F/A · filed 2024-04-22 |